Two-year follow-up results from an ongoing study on the safety and effectiveness of elexacaftor/tezacaftor/ivacaftor when used in real-world settings by people with cystic fibrosis
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2023 Mar 22;S1569-1993(23)00066-8. doi: 10.1016/j.jcf.2023.03.002.
Document
Link
Theme
Clinical Trials [3]
Pulmonology [4]
Keywords
Elexacaftor [5]
Ivacaftor [6]
Real-world [7]
registry [8]
Tezacaftor [9]
Date
Wednesday, March 22, 2023
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [10]